The use of hyperbaric oxygenation in neurological practice

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hyperbaric oxygenation (HBO) is traditionally considered a widespread additional method of therapy for various diseases that are associated with impaired tissue metabolism. Its use in neurological diseases of various origins is based on the significance of cerebral hypoxia as one of the leading pathogenetic factors. HBO increases blood oxygenation, which intensifies redox processes in tissues, improves cellular metabolism, decreases cerebral edema and intracranial pressure, and, ultimately, improves treatment results for neurological diseases of various pathogenesis. The use of HBO can form highly active oxygen compounds, some of which have antiviral activity. Therefore, taking the increased tissue oxygenation into account, HBO is considered a very promising treatment method for patients with coronavirus disease-2019.

HBO is recommended for carbon monoxide poisoning, stroke and poststroke disorders, dementia (including vascular dementia), and craniocerebral injury, as well as in craniocerebral injury consequences and benign intracranial hypertension. The results of using this method for headaches of vascular origin, polyneuropathies of various origins (including diabetic polyneuropathy), multiple sclerosis, and infantile cerebral palsy are less conclusive.

The existing contradictory opinions regarding the HBO protocol and the indications for the use of this treatment method require further research in this field.

Full Text

Restricted Access

About the authors

Igor’ V. Damulin

Moscow Research Institute of Psychiatry — Branch of the V.P. Serbsky National Medical Research Centre for Psychiatry and Narcology

Author for correspondence.
Email: damulin_igor@mail.ru
ORCID iD: 0000-0003-4826-5537

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

References

  1. Calvert JW, Cahill J, Zhang JH. Hyperbaric oxygen and cerebral physiology. Neurol Res. 2007;29(2):132–141. doi: 10.1179/016164107X174156
  2. Choudhury R. Hypoxia and hyperbaric oxygen therapy: a review. Int J Gen Med. 2018;11:431–442. doi: 10.2147/IJGM.S172460
  3. Drenjančević I. Introductory Chapter: Hyperbaric Oxygen Treatment: Old Treatment with New Understanding. In: Hyperbaric Oxygen Treatment in Research and Clinical Practice – Mechanisms of Action in Focus. IntechOpen; 2018:1–8. doi: 10.5772/intechopen.79866
  4. Jain KK. The Handbook of Neuroprotection. Second Edition. Springer Science, Human Press; 2019. doi: 10.1007/978-1-4939-9465-6
  5. McDonagh MS. Hyperbaric oxygen therapy in cerebral palsy. In: Cerebral Palsy. Ch.27. Springer International Publishing; 2018:283–293. doi: 10.1007/978-3-319-67858-0_27
  6. Jain KK. The Use of HBO in Treating Neurological Disorders. In: Textbook of Hyperbaric Medicine. Sixth Edition. Springer International Publishing; 2017:221–236. doi: 10.1007/978-3-319-47140-2_18
  7. Gunes AE. Toxic Effects of Hyperbaric Conditions. In: Hyperbaric Oxygen Treatment in Research and Clinical Practice – Mechanisms of Action in Focus. IntechOpen; 2018:109–120. doi: 10.5772/intechopen.78392
  8. Baugh MA. HIV: reactive oxygen species, enveloped viruses and hyperbaric oxygen. Med Hypotheses. 2000;55(3):232–238. doi: 10.1054/mehy.2000.1048
  9. Kuffler DP. Hyperbaric oxygen therapy: an overview. J Wound Care. 2010;19(2):77–79. doi: 10.12968/jowc.2010.19.2.46970
  10. Wilson DF, Matschinsky FM. Hyperbaric oxygen toxicity in brain: A case of hyperoxia induced hypoglycemic brain syndrome. Med Hypotheses. 2019;132:109375. doi: 10.1016/j.mehy.2019.109375
  11. Gul F, Boran OF, Arslantas R. Microcirculation and Hyperbaric Oxygen Treatment. In: Hyperbaric Oxygen Treatment in Research and Clinical Practice – Mechanisms of Action in Focus. IntechOpen: 2018. P. 47–66. doi: 10.5772/intechopen.75609
  12. Cardenas DP, Muir ER, Huang S, et al. Functional MRI during hyperbaric oxygen: Effects of oxygen on neurovascular coupling and BOLD fMRI signals. Neuroimage. 2015;119:382–389. doi: 10.1016/j.neuroimage.2015.06.082
  13. Cardenas DP, Muir ER, Duong TQ. MRI of cerebral blood flow under hyperbaric conditions in rats. NMR Biomed. 2016;29(7):961–968. doi: 10.1002/nbm.3555
  14. Micarelli A, Jacobsson H, Larsson SA, et al. Neurobiological insight into hyperbaric hyperoxia. Acta Physiol (Oxf). 2013;209(1):69–76. doi: 10.1111/apha.12116
  15. Uszler JM. Neurophysiologic SPECT Brain Function Imaging and Hyperbaric Oxygen Therapy. In: Textbook of Hyperbaric Medicine. Springer International Publishing AG, 2017:91–97. doi: 10.1007/978-3-319-47140-2_10
  16. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017;47(1):24–32. doi: 10.28920/dhm47.1.24-32
  17. De Maio A, Hightower LE. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones. 2020;25(5):717–720. doi: 10.1007/s12192-020-01121-0
  18. Geier MR, Geier DA. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Med Hypotheses. 2020;140:109760. doi: 10.1016/j.mehy.2020.109760
  19. Thibodeaux K, Speyrer M, Raza A, et al. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a re trospective case series. J Wound Care. 2020;29(Sup5a):S4–S8. doi: 10.12968/jowc.2020.29.Sup5a.S4
  20. Jain KK. HBO Therapy in Miscellaneous Neurological Disorders. In: Textbook of Hyperbaric Medicine. Sixth Edition. Springer International Publishing; 2017:365–370. doi: 10.1007/978-3-319-47140-2_24
  21. Shapira R, Solomon B, Efrati S, et al. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging. 2018;62:105–119. doi: 10.1016/j.neurobiolaging.2017.10.007
  22. Essex C. Hyperbaric oxygen and cerebral palsy: no proven benefit and potentially harmful. Developmental Medicine & Child Neurology. 2007;45(3):213–215. doi: 10.1111/j.1469-8749.2003.tb00934.x
  23. Sonn J, Meirovithz E, Mayevsky A. Hyperbaric Hyperoxia and the Brain in Vivo: The Balance between Therapy and Toxicity. Advances in Biomedical Photonics and Imaging. 2008:217–222. doi: 10.1142/9789812832344_0042
  24. Eynan M, Biram A, Mullokandov M, et al. The transition from day-to-night activity is a risk factor for the development of CNS oxygen toxicity in the diurnal fat sand rat (Psammomys obesus). Chronobiol Int. 2017;34(5):578–586. doi: 10.1080/07420528.2017.1281822
  25. Koch AE, Kahler W, Wegner-Brose H, et al. Monitoring of CBFV and time characteristics of oxygen-induced acute CNS toxicity in humans. Eur J Neurol. 2008;15(7):746–748. doi: 10.1111/j.1468-1331.2008.02158.x

Copyright (c) 2021 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies